Articles tagged with “iv-ketamine”
Evidence-based comparison of IV racemic ketamine and intranasal esketamine (Spravato) for treatment-resistant depression, examining mechanism differences, efficacy data, FDA status, cost, access, and side effects.
Clinical comparison of intravenous and oral ketamine for depression and pain, examining bioavailability, efficacy evidence, convenience, cost, monitoring requirements, and appropriate clinical settings.
Send corrections, provider questions, or advertising inquiries.